Sickle cell disease is a genetic disorder that causes lifelong suffering—here's what you need to know
Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen ...
Mitochondrial damage linked to beta-cell dysfunction in type 2 diabetes
Mitochondrial defects, however, are associated with the development of diseases such as type 2 diabetes. Patients who suffer from this disorder are unable to produce enough insulin or use the insulin ...
Armed robbery in Revesby2d
Sickle Cell Disease: Key Facts and Lifelong Impact
Right now, approximately 20 billion red blood cells are busy travelling through your blood vessels. They are delivering oxygen to all the different ...
Pixel 9 users report access to the T-Mobile Starlink satellite messaging beta
Satellite messaging through Starlink supports "medium resolution images, music & audio podcasts," in a comment by Musk. With ...
Cracking the Alzheimer's code: How brain trauma triggers a hallmark of the disease
A study at Lund University reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta—a hallmark of Alzheimer's disease. The findings ...
Science Media Centre13d
expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease
January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...
PharmiWeb12d
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England
Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...
labiotech1d
Monoclonal antibodies: are they the key to treating Alzheimer’s disease?
Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...
Caribou Biosciences (NASDAQ:CRBU) and SOPHiA GENETICS (NASDAQ:SOPH) Critical Survey
SOPHiA GENETICS (NASDAQ:SOPH – Get Free Report) and Caribou Biosciences (NASDAQ:CRBU – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the ...
Dewpoint Therapeutics Announces DPTX3496 as a Development Candidate for the Treatment of Colorectal, Breast, and Lung Cancers
Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel ...
Gamma Delta T Cell Cancer Therapy Clinical Trials Overview
China Emerging Key Player in Development Of Gamma Delta T Cell Cancer Therapy Says KUICK RESEARCHDelhi, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Global Gamma Delta T Cell Cancer Therapy Market Opportunity ...
SK Telecom Co., Ltd. (SKM) Q4 2024 Earnings Call Transcript
SK Telecom Co., Ltd. ( NYSE: SKM) Q4 2024 Results Conference Call February 12, 2025 1:00 AM ET Hee Jun Chung - Investor Relations Yang-Seob Kim - Chief Financial Officer Kim Ji Hoon - Head of AI ...